Degussa acquires ownership of CYRO from joint venture partner Cytec
Degussa's methacrylate activities will be combined with CYRO's activities in the Americas following closing. Degussa expects a smooth and rapid transition of CYRO's business into Degussa's operations based on their existing close working relationship.
As a result of this transaction, Degussa will consolidate its position as a leading global supplier of methylmethacrylates (MMA), specialty monomers and polymers. The agreement includes four manufacturing facilities in Wallingford (Connecticut), Fortier(Louisiana), Osceola (Arkansas), Sanford (Maine), research and development assets, and sales and technical service locations in North America. The business being acquired includes about 680 CYRO personnel.
Degussa views the acquisition as an exciting opportunity to position the Group for growth in innovative segments of the acrylic sheet market. In this way, Degussa will be able to establish a world class platform to supply the North and South American markets with specialty products such as functional (antigraffitti) sheets and newly designed sound barrier systems.
Other news from the department business & finance
These products might interest you
Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality
Spinsolve Benchtop NMR by Magritek
Spinsolve Benchtop NMR
Spinsolve is a revolutionary multinuclear NMR spectrometer that provides the best performance
HYPERION II by Bruker
FT-IR and IR laser imaging (QCL) microscope for research and development
Analyze macroscopic samples with microscopic resolution (5 µm) in seconds
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.